These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 35352378)
1. Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people. Nagata JM; McGuire FH; Lavender JM; Brown TA; Murray SB; Greene RE; Compte EJ; Flentje A; Lubensky ME; Obedin-Maliver J; Lunn MR Int J Eat Disord; 2022 May; 55(5):678-687. PubMed ID: 35352378 [TBL] [Abstract][Full Text] [Related]
2. Appearance and performance-enhancing drugs and supplements (APEDS): Lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people. Nagata JM; McGuire FH; Lavender JM; Brown TA; Murray SB; Compte EJ; Cattle CJ; Flentje A; Lubensky ME; Obedin-Maliver J; Lunn MR Eat Behav; 2022 Jan; 44():101595. PubMed ID: 35066385 [TBL] [Abstract][Full Text] [Related]
3. Community norms of the Muscle Dysmorphic Disorder Inventory (MDDI) among gender minority populations. Nagata JM; Compte EJ; McGuire FH; Lavender JM; Brown TA; Murray SB; Flentje A; Capriotti MR; Lubensky ME; Obedin-Maliver J; Lunn MR J Eat Disord; 2021 Jul; 9(1):87. PubMed ID: 34261536 [TBL] [Abstract][Full Text] [Related]
4. Associations among romantic and sexual partner history and muscle dysmorphia symptoms, disordered eating, and appearance- and performance-enhancing drugs and supplement use among cisgender gay men. Nagata JM; DeBenedetto AM; Brown TA; Lavender JM; Murray SB; Capriotti MR; Flentje A; Lubensky ME; Cattle CJ; Obedin-Maliver J; Lunn MR Body Image; 2022 Jun; 41():67-73. PubMed ID: 35228105 [TBL] [Abstract][Full Text] [Related]
5. Appearance and Performance-Enhancing Drugs and Supplements, Eating Disorders Symptoms, Drive for Muscularity, and Sexual Orientation in a Sample of Young Men. Ghaderi A; Welch E Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432606 [TBL] [Abstract][Full Text] [Related]
6. Community norms for the Eating Disorder Examination Questionnaire (EDE-Q) among gender-expansive populations. Nagata JM; Compte EJ; Cattle CJ; Flentje A; Capriotti MR; Lubensky ME; Murray SB; Obedin-Maliver J; Lunn MR J Eat Disord; 2020 Dec; 8(1):74. PubMed ID: 33292636 [TBL] [Abstract][Full Text] [Related]
7. Psychometric evaluation of the muscle dysmorphic disorder inventory (MDDI) among gender-expansive people. Compte EJ; Cattle CJ; Lavender JM; Brown TA; Murray SB; Capriotti MR; Flentje A; Lubensky ME; Obedin-Maliver J; Lunn MR; Nagata JM J Eat Disord; 2022 Jul; 10(1):95. PubMed ID: 35794647 [TBL] [Abstract][Full Text] [Related]
8. Use of appearance- and performance-enhancing drugs and substances is associated with eating disorder symptomatology among U.S. college students. Ganson KT; Cunningham ML; Murray SB; Nagata JM Eat Weight Disord; 2022 Aug; 27(6):2245-2250. PubMed ID: 35066818 [TBL] [Abstract][Full Text] [Related]
9. Investigating the factor structure and measurement invariance of the Eating Disorder Examination-Questionnaire (EDE-Q) in a community sample of gender minority adults from the United States. Nagata JM; Compte EJ; McGuire FH; Brown TA; Lavender JM; Murray SB; Capriotti MR; Flentje A; Lubensky ME; Lunn MR; Obedin-Maliver J Int J Eat Disord; 2023 Aug; 56(8):1570-1580. PubMed ID: 37163420 [TBL] [Abstract][Full Text] [Related]
10. Disordered Eating and Body Dissatisfaction in Transgender and Gender-Expansive Adults: An Evaluation and Integration of the Gender Minority Stress and Resilience and Tripartite Influence Models. Muratore LA; Flentje A; Schuster D; Capriotti MR Behav Ther; 2022 Sep; 53(5):869-886. PubMed ID: 35987545 [TBL] [Abstract][Full Text] [Related]
11. Predictors of eating-related psychopathology in transgender and gender nonbinary individuals. Uniacke B; Glasofer D; Devlin M; Bockting W; Attia E Eat Behav; 2021 Aug; 42():101527. PubMed ID: 34049054 [TBL] [Abstract][Full Text] [Related]
12. Disparities in self-reported eating disorders and academic impairment in sexual and gender minority college students relative to their heterosexual and cisgender peers. Simone M; Askew A; Lust K; Eisenberg ME; Pisetsky EM Int J Eat Disord; 2020 Apr; 53(4):513-524. PubMed ID: 31943285 [TBL] [Abstract][Full Text] [Related]
13. Examination of eating disorder psychopathology across sexual and gender identities among a Canadian sample. Hallward L; Nagata JM; Rodgers RF; Ganson KT Int J Eat Disord; 2023 Mar; 56(3):604-615. PubMed ID: 36493406 [TBL] [Abstract][Full Text] [Related]
14. Variability in eating disorder risk and diagnosis in transgender and gender diverse college students. Simone M; Hazzard VM; Askew AJ; Tebbe EA; Lipson SK; Pisetsky EM Ann Epidemiol; 2022 Jun; 70():53-60. PubMed ID: 35472489 [TBL] [Abstract][Full Text] [Related]
15. Abortion experiences and preferences of transgender, nonbinary, and gender-expansive people in the United States. Moseson H; Fix L; Ragosta S; Forsberg H; Hastings J; Stoeffler A; Lunn MR; Flentje A; Capriotti MR; Lubensky ME; Obedin-Maliver J Am J Obstet Gynecol; 2021 Apr; 224(4):376.e1-376.e11. PubMed ID: 32986990 [TBL] [Abstract][Full Text] [Related]
16. Internalization of muscularity and thinness ideals: Associations with body dissatisfaction, eating disorder symptoms, and muscle dysmorphic symptoms in at risk sexual minority men. Convertino AD; Elbe CI; Mendoza RR; Calzo JP; Brown TA; Siegel JA; Jun HJ; Corliss HL; Blashill AJ Int J Eat Disord; 2022 Dec; 55(12):1765-1776. PubMed ID: 36263690 [TBL] [Abstract][Full Text] [Related]
17. Use of Legal Appearance- and Performance-Enhancing Drugs and Substances: Findings from the Canadian Study of Adolescent Health Behaviors. Ganson KT; Hallward L; Cunningham ML; Murray SB; Nagata JM Subst Use Misuse; 2023; 58(2):289-297. PubMed ID: 36576273 [TBL] [Abstract][Full Text] [Related]